Introduction: Dolutegravir (DTG) dispersible tablet (DTG-DT) is a pediatric-friendly formulation. We aimed to describe the pharmacokinetics and virologic responses of generic DTG-DT in children weighing <20 kg.
Methods: Children living with HIV-1 and <7 years of age weighing 6 to <20 kg were eligible.